Adamas Pharmaceuticals IPO Research Information

Adamas Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Adamas Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Adamas Pharmaceuticals	ADMS - NASDAQ	$16.00-$18.00	$16.00	$16.85	3 million	4/10/2014
Underwriter(s): Credit Suisse, Piper Jaffray
Co-Manager(s): William Blair, Needham & Co.
Industry: Health Care
Filing(s): Filed 2014-03-05 Terms Added 2014-03-26

Adamas Pharmaceuticals Quote & Chart - Click for current quote - ADMS

About Adamas Pharmaceuticals (adapted from Adamas Pharmaceuticals prospectus):
They are a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ADMS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.